Renal LC Flashcards
Hb and iron studies
Hb 100-110
Aim ferritin >200 and Tsat >20%
Renal complications
Blood:
anemia
Bones:
CKD-MBD
Electrolytes:
HyperK, metabolic acidosis (aim HCO2 <23), hyperphosphatemia
Neurology:
Peripheral neuropathy, sleep apnea, restless legs syndrome, fatigue/depression
Cardiac:
IHD, HTN
GI:
Anorexia, LOW
+ Volume overload
KDIGO CKD stages by egfr
1 - egr >90
2 - 60-89
3A - 40-59
3B - 30-44
DIALYSIS TERRITORY (refer)
4 - 15-29
5 - <15
*make sure to include micro/macroalbuminuria!
Indications for dialysis in CKD
Urgent - uremic encephalopathy/pericarditis/pleuritis
Non-urgent - declining nutritional status, refractory volume overload, worsening fatigue, MCI, refractory electrolyte disturbances (acidosis, hyperkalemia, hyperphosphatemia)
Factors contributing to secondary hyperparathyroidism in CKD
Phosphate retention
Decreased free ionized calcium
Decreased activated vitamin D
Increased FGF23
Lipid profile in CKD
Increased LDL, TG, VLDL
Decreased HDL
When should statins be prescribed in CKD?
Age >50
Age <50 + + one or more of:
- CAD
- stroke
- diabetes
- estimated 10 year incidence of MACE >10%
What foods are high in potassium?
Fruit - bananas, dried apricots, avocados, citrus
Veg - green leafy, potatos
Other - chocolate, milk, yoghurt
Indicators of adequacy of dialysis
Symptoms (poor corelation) - fluid balance, uremia
UEs - normalization of K, urea reducation ratio >70% in HDx; weekly normalized urea clearance >2.0, Kt/V (target ~1.7)
Absolute contraindications to renal transplant
Life expectancy problems
- Malignancy in the last 5 years (except prostate)
- Untreatable focus of infection
- Severe external disease
Surgical problems:
- Severe peripheral arterial/cerebrovascular disease
- Uncorrectable coagulopathy
Reversible problems:
- Reversible kidney failure
- BMI >35kg
Psychosocial problems:
- Documented ongoing treatment nonadherence (BUT EXPLORE THIS++++)
- Smoking/drug/alcohol dependence in last 6 months
- Significant untreatable psychosocial issues which would impair post-transplant care adherence
Define CKD-MBD
One or more of
- Abnormalities of calcium, phosphate, parathyroid hormone (PTH), or vitamin D metabolism
- Abnormalities in bone turnover, mineralisation, volume, linear growth, or strength
- Vascular or other soft tissue calcification
Findings in secondary hyperparathyroidism
Elevated serum phosphate Low serum calcium Low serum vitamin D High serum PTH ALP (bone origin) may also be elevated
Findings in tertiary hyperparathyroidism
Elevated, normal or low serum phosphate
Elevated serum calcium
Very high serum PTH
Forms of renal osteodystrophy
- adynamic bone disease
- osteomalacia
- osteitis fibrosa cystica
- mixed uremic osteodystrophy
Management of CKD-MBD
Target PTH 2-9 ULN
Normalize calcium
Normalize phosphate - diet, phosphate binders (calcium carbonate, sevalelamer)
Activated vitamin D (calcitriol) once phosphate normalized
Cinacalcet in dialysis patients (increase sensitivity of calcium sensing receptor in PTH gland)
Parathyroidectomy